Optical flow

RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy

Retrieved on: 
星期四, 二月 22, 2024
Retinitis pigmentosa, Liver, OTCQB, Cancer, Cataract, Alzheimer's disease, MD, Inflammation, Retina, Systemic disease, Patent, Swelling, Huntington's disease, Eye, Geography, Optical flow, Disease, Connective tissue, Biomarker, Anatomy, Kidney disease, Emaciation, Heart, Diagnosis, Conformation, Risk, Atrophy, Element, Cystic fibrosis, Parkinson's disease, Brain, Medical imaging

PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”) today announced that it has been granted a patent by the United States Patent and Trademark Office for the Company's System And Method For Visualization Of Ocular Anatomy.

Key Points: 
  • PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”) today announced that it has been granted a patent by the United States Patent and Trademark Office for the Company's System And Method For Visualization Of Ocular Anatomy.
  • The present invention relates to systems and methods for visualizing eye anatomy for diagnostic and therapeutic purposes.
  • Furthermore, it allows for the detection and analysis of various conditions of the eye, such as, hydration, innervations, inflammation, circulation, nerve conduction, etc.
  • Some of the best-studied ocular conformational diseases include cataracts in the lens and retinitis pigmentosa in the retina.

Lumicell Announces Initial Data Demonstrating LUMISIGHT™’s Ability to Detect Tumors Metastasized to Multiple Organs in the Peritoneum

Retrieved on: 
星期二, 二月 20, 2024
Research, Medical Devices, Surgery, Clinical Trials, Health Technology, Biotechnology, Radiology, Health, Science, Oncology, Society, Survival, Massachusetts General Hospital, Peritoneum, Hospital, Optical flow, Peritoneal cavity, Surgical oncology, Associate, Patient, Dentistry

The ongoing study is utilizing the investigational LUMISIGHT optical imaging drug and accompanying imaging device to distinguish tumor metastases to organs within the peritoneum.

Key Points: 
  • The ongoing study is utilizing the investigational LUMISIGHT optical imaging drug and accompanying imaging device to distinguish tumor metastases to organs within the peritoneum.
  • “This data advances the potential for image-guided surgery to detect small tumors and metastases to organs in the peritoneal cavity which could provide better outcomes for our patients,” said Dr. Cusack.
  • “Further innovation is desperately needed to improve the benefits of cytoreductive surgery for this invasive and elusive cancer.
  • Everything we do at Lumicell is focused on improving surgical outcomes for patients,” said Howard Hechler, President of Lumicell.

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities

Retrieved on: 
星期四, 二月 8, 2024
Patent, Wireless, 3D, BOCA, Vision, Suggestion, Optical flow

BOCA RATON, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued Patent No.

Key Points: 
  • BOCA RATON, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that the U.S. Patent and Trademark Office (USPTO) has issued Patent No.
  • 11,894,123 B2, titled “Radiotherapy Mobile and Wireless Device Workflow Management System.”
    This new patent covers systems and methods for treating a patient with a radiotherapy system combining high-frequency ultrasound and optical imaging data.
  • This proprietary technology is essentially a treatment-planning system that is made possible by fusing together a radiation therapy device with a high-frequency ultrasound (the SRT-100 Vision).
  • “The SRT-100 Vision (IG-SRT) is increasingly important to Sensus, and this new U.S. patent adds to our valuable intellectual property portfolio comprised of both domestic and international patents,” said Michael Sardano, president and general counsel of Sensus Healthcare.

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Retrieved on: 
星期一, 一月 29, 2024
Research, Anker Innovations, Smartphone, Optical flow, Stock, Vlog, Growth

SHANGHAI and SHENZHEN, China, Jan. 29, 2024 /PRNewswire/ -- The 2023 Forbes China Globalization Innovators Selection 30&30 awards ceremony in Shanghai announced the 2023 Forbes China Globalization Innovators Top30, a list celebrating 30 entrepreneurs whose companies have achieved significant international growth and recognition. Notable honorees include Shou Zi Chew, CEO of TikTok; Yang Huahua, Chief Supply Chain Officer of Anker Innovations; and Zhou Yang, Founder and Chairman of SmallRig, a brand under the corporate umbrella of Shenzhen Leqi Network Technology Co., Ltd.

Key Points: 
  • SHANGHAI and SHENZHEN, China, Jan. 29, 2024 /PRNewswire/ -- The 2023 Forbes China Globalization Innovators Selection 30&30 awards ceremony in Shanghai announced the 2023 Forbes China Globalization Innovators Top30, a list celebrating 30 entrepreneurs whose companies have achieved significant international growth and recognition.
  • Notable honorees include Shou Zi Chew, CEO of TikTok; Yang Huahua, Chief Supply Chain Officer of Anker Innovations; and Zhou Yang, Founder and Chairman of SmallRig, a brand under the corporate umbrella of Shenzhen Leqi Network Technology Co., Ltd.
  • The Forbes China list is a testament to the global ambitions of Chinese brands and their leaders' understanding of overcoming the challenges of international expansion.
  • Among these, SmallRig is highlighted for its pivotal role in demonstrating the capacity of Chinese companies to scale globally.

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Retrieved on: 
星期一, 一月 29, 2024
Research, Anker Innovations, Multimedia, Smartphone, Optical flow, Stock, Vlog, Growth, Video game

SHANGHAI and SHENZHEN, China, Jan. 29, 2024 /PRNewswire/ -- The 2023 Forbes China Globalization Innovators Selection 30&30 awards ceremony in Shanghai announced the 2023 Forbes China Globalization Innovators Top30, a list celebrating 30 entrepreneurs whose companies have achieved significant international growth and recognition. Notable honorees include Shou Zi Chew, CEO of TikTok; Yang Huahua, Chief Supply Chain Officer of Anker Innovations; and Zhou Yang, Founder and Chairman of SmallRig, a brand under the corporate umbrella of Shenzhen Leqi Network Technology Co., Ltd.

Key Points: 
  • SHANGHAI and SHENZHEN, China, Jan. 29, 2024 /PRNewswire/ -- The 2023 Forbes China Globalization Innovators Selection 30&30 awards ceremony in Shanghai announced the 2023 Forbes China Globalization Innovators Top30, a list celebrating 30 entrepreneurs whose companies have achieved significant international growth and recognition.
  • Notable honorees include Shou Zi Chew, CEO of TikTok; Yang Huahua, Chief Supply Chain Officer of Anker Innovations; and Zhou Yang, Founder and Chairman of SmallRig, a brand under the corporate umbrella of Shenzhen Leqi Network Technology Co., Ltd.
  • The Forbes China list is a testament to the global ambitions of Chinese brands and their leaders' understanding of overcoming the challenges of international expansion.
  • With over 720 SKUs, SmallRig caters to a wide range of imaging needs, establishing a strong brand presence in international markets.

NuraLogix Unveils Anura™ MagicMirror™ Creating New Possibilities for Health Measurement

Retrieved on: 
星期二, 一月 9, 2024
Transdermal optical imaging, Digital health, Patient, School, Mental health, Algorithm, Movement, Pharmacy, Vital signs, CES, Machine learning, Optical flow

LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- CES -- NuraLogix, a global pioneer in Affective Ai™1, is pleased to announce Anura™ MagicMirror™, a first-of-its-kind tabletop smart mirror that analyzes facial blood flow information to accurately calculate a host of vital signs and disease risk assessments. Powered by the company's cloud-based Affective Ai™ platform DeepAffex™, Anura™ MagicMirror™ is the first device NuraLogix has manufactured, leveraging its hardware-agnostic software to deliver on the promise of making accurate health data ubiquitous in people's lives.

Key Points: 
  • Powered by the company's cloud-based Affective Ai™ platform DeepAffex™, Anura™ MagicMirror™ is the first device NuraLogix has manufactured, leveraging its hardware-agnostic software to deliver on the promise of making accurate health data ubiquitous in people's lives.
  • A CES 2024 Innovation Award Honoree for Digital Health, Anura™ MagicMirror™ is being showcased at the NuraLogix booth #8917 in the North Hall throughout the CES show in Las Vegas.
  • Anura ™ MagicMirror™ is designed for conducting speedy and accurate physical and mental health assessments anywhere, anytime.
  • Uniquely, it can measure physical health vitals, as well as mental health assessments, and can carry out health risk assessments.

North America Dominates the Preclinical Imaging Market in 2022 Due to Advanced Research Infrastructure - ResearchAndMarkets.com

Retrieved on: 
星期二, 十月 24, 2023
Radiology, Health, Research, Vega, National Conference, MRI, Smartphone, Scan (company), Drug discovery, Biotechnology, India, Conference, Automated Imaging Association, Infection, Kidney, PerkinElmer, Cosmetics, PET, Arietta, Cardiology, Development, PAT, Connect, Neurology, CT, Optical flow, Traction, USD, Abdominal ultrasonography, SPECT, Cancer, X-ray, Compound annual growth rate, Medical imaging

The global preclinical imaging market is poised for substantial growth, with a projected size of USD 5.95 billion by 2030.

Key Points: 
  • The global preclinical imaging market is poised for substantial growth, with a projected size of USD 5.95 billion by 2030.
  • The market is expected to expand at a Compound Annual Growth Rate (CAGR) of 4.74% from 2023 to 2030.
  • Heavy investments in research and development worldwide are driving research projects and, subsequently, the demand for preclinical imaging.
  • Advancements in high-throughput ultrasound imaging systems used in cancer research and studies have further driven market growth.

Optical Imaging Leads Global Preclinical Imaging Market with 13.6% Share in 2022

Retrieved on: 
星期五, 十月 20, 2023
Research, Vega, National Conference, MRI, Smartphone, Scan (company), Drug discovery, Biotechnology, India, Conference, Automated Imaging Association, Infection, Kidney, PerkinElmer, Cosmetics, PET, Arietta, Cardiology, Development, PAT, Connect, Neurology, CT, Optical flow, Traction, USD, Abdominal ultrasonography, SPECT, Cancer, X-ray, Compound annual growth rate, Medical imaging

The global preclinical imaging market is poised for substantial growth, with a projected size of USD 5.95 billion by 2030.

Key Points: 
  • The global preclinical imaging market is poised for substantial growth, with a projected size of USD 5.95 billion by 2030.
  • The market is expected to expand at a Compound Annual Growth Rate (CAGR) of 4.74% from 2023 to 2030.
  • Heavy investments in research and development worldwide are driving research projects and, subsequently, the demand for preclinical imaging.
  • Preclinical imaging finds applications across a wide range of sectors, including pharmaceuticals, biotechnology, life sciences, medical devices, cosmetics, veterinary hospitals, and educational institutions.

Gold Nanoparticles Market Research Report 2023 - ResearchAndMarkets.com

Retrieved on: 
星期一, 十月 16, 2023
Technology, Biotechnology, Nanotechnology, Health, Food, COVID-19, Biomarker, Optical flow, Nanosphere lithography, Gold, Nanoparticle, Magnetic resonance imaging, PET, R, Electronics, CT, MRI, Nanocluster, Nanoshell, Solubility, Research, Palladium, Medical imaging, Potash, Growth

The "Gold Nanoparticles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gold Nanoparticles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global gold nanoparticles market size reached US$ 4.9 Billion in 2022.
  • Gold nanoparticles, denoted as AuNPs, are tiny gold particles with diameters ranging from 1 to 100 nanometers (nm).
  • What is the structure of the global gold nanoparticles market and who are the key players?

Global Gold Nanoparticles Market Research Report 2023-2028: AuNPs Illuminate Disease Detection with Advanced Optical Imaging Techniques

Retrieved on: 
星期三, 十月 11, 2023
Food, COVID-19, Biomarker, Optical flow, Nanosphere lithography, Gold, Nanoparticle, Magnetic resonance imaging, PET, R, Electronics, CT, MRI, Nanocluster, Nanoshell, Solubility, Research, Palladium, Medical imaging, Potash, Growth

DUBLIN, Oct. 11, 2023 /PRNewswire/ -- The "Gold Nanoparticles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 11, 2023 /PRNewswire/ -- The "Gold Nanoparticles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • Gold nanoparticles, denoted as AuNPs, are tiny gold particles with diameters ranging from 1 to 100 nanometers (nm).
  • Key Questions Answered in This Report:
    How has the global gold nanoparticles market performed so far and how will it perform in the coming years?
  • What is the structure of the global gold nanoparticles market and who are the key players?